Compile Data Set for Download or QSAR
Report error Found 90 of affinity data for UniProtKB/TrEMBL: Q9WRL0
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427523(US10544141, Compound 693)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427535(US10544141, Compound 789)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427534(US10544141, Compound 661)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427533(US10544141, Compound 788)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427532(US10544141, Compound 660)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427531(US10544141, Compound 787)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427530(US10544141, Compound 700)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427529(US10544141, Compound 786)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427528(US10544141, Compound 696)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427527(US10544141, Compound 785)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427526(US10544141, Compound 694)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427525(US10544141, Compound 784)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427536(US10544141, Compound 662)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427522(US10544141, Compound 783)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427521(US10544141, Compound 644)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427520(US10544141, Compound 782)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427519(US10544141, Compound 642)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427518(US10544141, Compound 669)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427517(US10544141, Compound 604)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427516(US10544141, Compound 388)
Affinity DataEC50: >1.00E+4nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427515(US10544141, Compound 241)
Affinity DataEC50: >1.00E+4nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427514(US10544141, Compound 260)
Affinity DataEC50: >1.00E+4nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427513(US10544141, Compound 238)
Affinity DataEC50: >1.00E+4nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427546(US10544141, Compound 762)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427562(US10544141, Compound 668)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427561(US10544141, Compound 666)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427560(US10544141, Compound 667)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427559(US10544141, Compound 759)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427558(US10544141, Compound 765)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427557(US10544141, Compound 758)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427550(US10544141, Compound 764)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427549(US10544141, Compound 757)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427548(US10544141, Compound 763)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427547(US10544141, Compound 744)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427512(US10544141, Compound 971)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427545(US10544141, Compound 742)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427543(US10544141, Compound 760)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427544(US10544141, Compound 440)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427543(US10544141, Compound 760)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427542(US10544141, Compound 665)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427541(US10544141, Compound 792)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427540(US10544141, Compound 664)
Affinity DataEC50:  300nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427539(US10544141, Compound 791)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427538(US10544141, Compound 663)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427537(US10544141, Compound 790)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427491(US10544141, Compound 548)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427499(US10544141, Compound 929)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427498(US10544141, Compound 928)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427498(US10544141, Compound 928)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandPNGBDBM427497(US10544141, Compound 927)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: